The Proportion of Catagen and Telogen Hair Follicles in Occipital Scalp of Male Androgenetic Alopecia Patients: Challenging the Established Dogma

    October 2024 in “ Experimental Dermatology
    Francisco Jiménez, Majid Alam
    Image of study
    TLDR The belief about hair shedding phases is likely incorrect and needs reevaluation.
    The study, conducted on 14 Caucasian males with androgenetic alopecia, challenges the traditional belief that 10%-15% of scalp hair follicles are in the telogen phase and 1%-2% in the catagen phase. It found that 7.5% of follicles are in catagen and 3.5% in telogen, suggesting a need to reevaluate the current understanding of hair follicle phase distribution. The research highlights the limitations of traditional methods in distinguishing between these phases and emphasizes the accuracy of ex vivo stereomicroscopic and histologic evaluations. The findings suggest that the common belief of shedding up to 100 hairs per day may be incorrect and call for further research using more rigorous methods.
    Discuss this study in the Community →

    Research cited in this study

    21 / 21 results

    Related Community Posts Join

    6 / 40 results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  44 upvotes 5 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community Hair greed made me switch to Dut too early

      in Chat  42 upvotes 3 weeks ago
      The user switched from finasteride to dutasteride for hair loss but faced increased shedding and anxiety, regretting not staying with finasteride longer. Other users shared mixed experiences, advising patience with dutasteride, as it may take up to a year to show results.

      community My scalp punch biopsy results🤔?

      in Female  7 upvotes 2 years ago
      Female using Rogaine foam for hair loss had scalp punch biopsy, diagnosed with Androgenetic Alopecia (AGA). Doctor recommended starting Spironolactone 50mg.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  38 upvotes 2 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

    Related Research

    3 / 3 results